Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells.
Article in Journal of General Virology (January 2021)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Journal of General Virology (January 2021)
Book chapter (April 2017)